References
- Grosse P, Schulz J, Schmierer K. Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis. Lancet Neurol 2003; 8: 512
- National Committee for Clinical Laboratory Standards (NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts – 2nd Edition: Approved Standard M27-A2 (2002) Wayne, PA, USA: NCCLS.
- Rex JH, Pfaller MA, Galgiani JN, et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis 1997; 24: 235–247
- Denning DW, Armstrong RW, Eishman M, Stevens DA. Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole. Rev Infect Dis 1991; 13: 1126–1130
- Crump JR, Elner SG, Elner VM, Kauffman CA. Cryptococcal endophthalmitis: case report and review. Clin Infect Dis 1992; 14: 1069–1073
- Park MK, Hospenthal DR, Bennett JE. Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. Clin Infect Dis 1999; 28: 629–633
- Tang LM. Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus. Surg Neurol 1990; 33: 314–319
- Magham D, Gerding DN, Peterson LR, Sarori GA. Fungal meningitis presenting as hydrocephalus. Arch Intern Med 1983; 143: 728–731
- Walsh TJ, Schlegel R, Moody MM, Costerton JW, Salcman M. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructual and quantitative microbiological study. Neurosurgery 1986; 18: 373–375
- Crum CP, Feldman PS. Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis. Human Path 1981; 12: 660–663
- Yadav SS, Perfect J, Friedman AH. Successful treatment of cryptococcal ventricular shunt infection with systemic therapy alone. Neurosurgery 1988; 23: 372–373
- Ingram CW, Haywood HB, 3rd, Morris VM, Allen RL, Perfect JR. Cryptococcal ventricular-peritoneal shunt infection: Clinical and epidemiological evaluation of two closely associated cases. Infect Control Hosp Epidemiol 1993; 14: 719–722
- Hossain MA, Mukherjee PK, Reyes G, Long L, Ghannoum MA. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model. J Chemother 2002; 14: 351–360
- Mayanja-Kizza H, Oishi K, Mitarashi S, et al. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis 1998; 26: 1362–1366
- Yadav SS, Perfect J, Friedman AH. Successful treatment of cryptococcal ventricular shunt infection with systemic therapy alone. Neurosurgery 1988; 23: 372–373
- Martinez LR, Casadevall A. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 2006; 50: 1021–1033
- Mian UK, Mayers M, Garg Y, et al. Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state. J Ocul Pharmacol Ther 1998; 14: 459–471
- Abbasoglu OE, Hosal BM, Sener B, Erdemoglu N, Gursel E. Penetration of topical fluconazole into human aqueous humor. Exp Eye Res 2001; 72: 147–151
- Kwon-Chung KJ, Polacheck I, Bennett JE. Cryptococcosis. Medical Mycology, KJ Kwon-Chung, JE Bennett. Lea & Febiger, Philadelphia 1992; 397–446